hemophilus

(redirected from Haemophilus)
Also found in: Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Translations

hemophilus

, haemophilus
n. hemófilo, bacteria anaeróbica gram-negativa del género Haemophilus.
References in periodicals archive ?
Electronic auction: re-auction in electronic form for the right to conclude a contract for the supply of specific medications (vaccine for the prevention of diphtheria and tetanus adsorbed, pertussis acellular, polio inactivated, infection caused by haemophilus influenzae type b conjugated) to provide stationary medical organizations of the city of moscow (unz 181489)
USPRwire, Thu Nov 02 2017] Haemophilus influenzae Type B Infections - Pipeline Review, H2 2015 Summary Global Markets Direct s, Haemophilus influenzae Type B Infections - Pipeline Review, H2 2015 , provides an overview of the Haemophilus influenzae Type B Infections s therapeutic pipeline.
Haemophilus influenzae can be encapsulated (serotypes a-f) or unencapsulated, nontypeable (NTHi) (1).
Bacteria pathogens that are the leading causes of otitis media are Streptococcus pneumoniae (25-50%), non-typeable Haemophilus influenzae (15-30%), andMoraxella catarrhalis (3-20%) (6-8).
Haemophilus influenzae is a common Gram-negative human-restricted bacterial pathogen that frequently colonises the nasopharynx in healthy individuals and can cause local infections such as otitis media, sinusitis, pneumonia, or exacerbations of chronic obstructive pulmonary disease (COPD).
Aggregatibacter aphrophilus (formerly Haemophilus aphrophilus) is an aerobic gram-negative coccobacillus that belongs to the HACEK (Haemophilus aphrophilus/paraphrophilus, Actino bacillus actinomycetem comitans, Cardiobacterium hominis, Eikenella corrodens and Kingella spp.
Infections caused by Neisseria meningitidis (Nm), Streptococcus pneumoniae (Sp) and Haemophilus influenzae (Hi) are responsible for high morbidity and mortality rates among children and adults in many countries each year.
Global Markets Direct's, 'Haemophilus influenzae Type B Infections - Pipeline Review, H1 2016', provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape.
Hiberix was first licensed in the United States in August 2009 for use as a booster dose in children aged 15 months through 4 years under the Accelerated Approval Regulations, in response to a Haemophilus influenzae type b (Hib) vaccine shortage that lasted from December 2007 to July 2009 (1).
Background: The pathogenesis of nontypeable Haemophilus influenzae (NTHi) begins with adhesion to the rhinopharyngeal mucosa.
Synovial fluid cultures from the initial arthrocentesis were now growing Haemophilus parainfluenzae with colonies observed on solid media within 24 hours of inoculation.
UKPRwire, Wed Dec 10 2014] Global Markets Direct's, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2014', provides an overview of the Haemophilus Influenzae Type b Infections's therapeutic pipeline.